MINNEAPOLIS--(BUSINESS WIRE)--Possis Medical, Inc. (NASDAQ:POSS) announced that Dr. Georgios Sianos of the Thoraxcentre in Rotterdam, the Netherlands, today presented compelling results showing the clinical value of AngioJet® treatment for coronary arterial thrombus in heart attack patients at the 2006 Transcatheter Cardiovascular Therapeutics (TCT) conference in Washington, D.C. TCT, which is taking place October 22-27, is the premier venue for interventional clinical science. Dr. Sianos’ results show that AngioJet thrombectomy in heart attack patients with large thrombus prior to treatment with drug eluting stents markedly reduces the incidence of stent thrombosis in follow-up out to two years.
